REGENXBIO Statistics Share Statistics REGENXBIO has 50.39M
shares outstanding. The number of shares has increased by 1.95%
in one year.
Shares Outstanding 50.39M Shares Change (YoY) 1.95% Shares Change (QoQ) 0.6% Owned by Institutions (%) 80.58% Shares Floating 45.78M Failed to Deliver (FTD) Shares 957 FTD / Avg. Volume 0.1%
Short Selling Information The latest short interest is 6.18M, so 12.26% of the outstanding
shares have been sold short.
Short Interest 6.18M Short % of Shares Out 12.26% Short % of Float 14.9% Short Ratio (days to cover) 11.26
Valuation Ratios The PE ratio is -1.69 and the forward
PE ratio is -5.15.
REGENXBIO's PEG ratio is
0.07.
PE Ratio -1.69 Forward PE -5.15 PS Ratio 4.59 Forward PS 1.3 PB Ratio 1.47 P/FCF Ratio -2.18 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for REGENXBIO.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.69,
with a Debt / Equity ratio of 0.32.
Current Ratio 2.69 Quick Ratio 2.69 Debt / Equity 0.32 Debt / EBITDA -0.41 Debt / FCF -0.47 Interest Coverage -18.43
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $236.06K Profits Per Employee $-643.35K Employee Count 353 Asset Turnover 0.18 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -37.57% in the
last 52 weeks. The beta is 1.11, so REGENXBIO's
price volatility has been higher than the market average.
Beta 1.11 52-Week Price Change -37.57% 50-Day Moving Average 8.8 200-Day Moving Average 8.33 Relative Strength Index (RSI) 39.72 Average Volume (20 Days) 916,374
Income Statement In the last 12 months, REGENXBIO had revenue of 83.33M
and earned -227.1M
in profits. Earnings per share was -4.59.
Revenue 83.33M Gross Profit 49.76M Operating Income -233.35M Net Income -227.1M EBITDA -198.23M EBIT -214.44M Earnings Per Share (EPS) -4.59
Full Income Statement Balance Sheet The company has 57.53M in cash and 82.03M in
debt, giving a net cash position of -24.51M.
Cash & Cash Equivalents 57.53M Total Debt 82.03M Net Cash -24.51M Retained Earnings -932.15M Total Assets 581.03M Working Capital 254.21M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -173.13M
and capital expenditures -2.44M, giving a free cash flow of -175.56M.
Operating Cash Flow -173.13M Capital Expenditures -2.44M Free Cash Flow -175.56M FCF Per Share -3.55
Full Cash Flow Statement Margins Gross margin is 59.72%, with operating and profit margins of -280.03% and -272.54%.
Gross Margin 59.72% Operating Margin -280.03% Pretax Margin -272.54% Profit Margin -272.54% EBITDA Margin -237.89% EBIT Margin -280.03% FCF Margin -210.69%
